Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.
Read Also
- Costner, Gere, Demi Moore: Hollywood icons on Cannes comeback trail
- CoreWeave Raises $7.5 Billion in Debt for AI Computing Push
- Speculation Swirls in Slovakia, With Details About Fico Attack Scant
- Aid trucks begin moving ashore via Gaza pier, U.S. says
- Coppola's long-awaited epic 'Megalopolis' divides Cannes
- China pledges $42 billion in a slew of measures to support the struggling property sector
- Paul McCartney becomes UK's first billionaire musician
- As Supernatural Claims Spread Online, Vatican Updates Its Rules on Them
- Pakistan hit by suspected militant bombing of girl's school in former Taliban stronghold
- Israel rejects South Africa’s ICJ plea for Rafah attack halt
Latest Al Jazeera
- Israel rejects South Africa’s ICJ plea for Rafah attack halt
- Russia’s Putin eyes greater support from China for Ukraine war effort
- French police kill man suspected of setting fire to synagogue in Rouen
- South Korean military says North Korea test-fired ‘ballistic missiles’
- As Israel attacked Gaza’s north, 26 members of his family were wiped out
- Does India risk US sanctions over Iran’s Chabahar Port deal?
- The misogyny of the anti-protest
- Colombia hunts for assailants after Bogota prison director shot dead
- Two officers killed in suspected JI attack on Malaysian police station
- What is Trident, the US floating pier off Gaza? Will it work?